Chinese Journal of Tissue Engineering Research ›› 2019, Vol. 23 ›› Issue (36): 5741-5746.doi: 10.3969/j.issn.2095-4344.1942

    Next Articles

Total joint arthroplasty in the treatment of advanced hemophilia A arthropathy

Gao Qiang, Liu Wei, Li Jiale, Jing Juehua, Yao Yunfeng   

  1. Department of Orthopedics, The Second Hospital, Anhui Medical University, Hefei 230601, Anhui Province, China
  • Online:2019-12-28 Published:2019-12-28
  • Contact: Yao Yunfeng, Associate professor, Chief physician, Master’s supervisor, Department of Orthopedics, The Second Hospital, Anhui Medical University, Hefei 230601, Anhui Province, China
  • About author:Gao Qiang, Master candidate, Department of Orthopedics, The Second Hospital, Anhui Medical University, Hefei 230601, Anhui Province, China
  • Supported by:

    the General Program of Natural Science Foundation of Anhui Province, No. 1608085MH167 (to YYF)

Abstract:

BACKGROUND: Hemophilia arthritis is the dysfunction of multiple joints caused by hemophilia, in which the incidence of hip and knee joint is high. Total joint arthroplasty is an effective method for the treatment of hemophilia arthritis, which can improve the quality of life of patients, reduce the dysfunction of affected limbs and prolong the life span of patients.
OBJECTIVE: To investigate the clinical efficacy of total joint arthroplasty in the treatment of advanced hemophilia A arthropathy.
METHODS: The clinical data of 14 patients with advanced hemophilia A arthropathy (11 knees and 9 hips) from June 2015 to February 2019 were analyzed retrospectively. Totally 11 knees underwent total knee arthroplasty, and 9 hips underwent total hip arthroplasty. All patients were male with a mean age of 38.6±9.9 years. One case received intraoperative transfusion of 300 mL, and two cases received blood transfusion of 200 mL after operation. In the perioperative period, the coagulation factor replacement therapy was used to select (500 IU) recombinant human coagulation factor Ⅷ, perioperatively. The detection of factor Ⅷ inhibitors was zero. All patients signed the informed consent. This study was approved by the Hospital Ethics Committee. Knee function after total knee arthroplasty was assessed using the Hospital for Special Surgery Knee Score and the American Knee Society Score. Hip function was evaluated after total hip arthroplasty by Harris score. Visual analogue score and the activity of the factor Ⅷ were compared before and after operation. Bleeding, infection and prosthetic loosening were observed.
RESULTS AND CONCLUSION: (1) Fourteen patients were followed-up for 12-45 months. No complications such as revision, prosthetic loosening or joint infection were found in all patients after operation. (2) The Hospital for Special Surgery score was increased from (30.1±9.5) preoperatively to (82.1±10.7) after one-year follow-up. The clinical score of Knee Society Score was increased from (29.1±15.4) preoperatively to (89.3±7.0) after one-year follow-up, and the functional score of Knee Society Score was increased from (18.6±13.6) preoperatively to (72.3±16.6) after one-year follow-up. The Harris score of total hip arthroplasty was increased from (34.6±10.7) preoperatively to (85.8 ±4.8) after one-year follow-up (P < 0.05). The visual analogue score was decreased from (6.0±2.4) preoperatively to (1.0±0.9) after one-year follow-up, and the activity of the factor Ⅷ was increased from (1.9±2.0)% preoperatively to (108.6±20.7)% on the first day after operation (P < 0.05). (3) The clinical efficacy of total joint arthroplasty under coagulation factor substitution for advanced hemophilia A arthropathy is outstanding. It can significantly improve the joint function, correct deformation, reduce pain, and improve the long-term quality of life of the patients.

Key words: hemophilia A arthropathy, total knee arthroplasty, total hip arthroplasty, follow-up, pain, coagulation factor

CLC Number: